Companies / Cytokinetics Inc / Activity
Activity — Cytokinetics Inc
157 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Lee Sung Executive | Sell | Common Stock | $3.19M | -39K -37.99% | 63,221 0.05% of shares | medium |
| May 5, 2026 | Lee Sung Executive | Sell | Common Stock | $1.84M | -24K -27.44% | 63,221 0.05% of shares | medium |
| May 5, 2026 | Henderson John T Director | Sell | Common Stock | $1.52M | -20K -21.00% | 75,237 0.05% of shares | medium |
| Mar 17, 2026 | Blum Robert I CEO | Sell | Common Stock | $1.49M | -24K -5.27% | 430,330 0.31% of shares | medium |
| Jun 24, 2026 | Lee Sung Executive | Exercise | Common Stock | $1.13M | +23K +36.97% | 86,591 0.06% of shares | low |
| Jun 1, 2026 | Callos Andrew Executive | Sell | Common Stock | $1.11M | -15K -20.39% | 58,555 0.04% of shares | medium |
| May 1, 2026 | Callos Andrew Executive | Sell | Common Stock | $1.03M | -16K -21.31% | 58,555 0.04% of shares | medium |
| Apr 30, 2026 | Callos Andrew Executive | Sell | Common Stock | $948.9K | -15K -20.39% | 58,555 0.04% of shares | medium |
| Feb 5, 2026 | Callos Andrew Executive | Sell | Common Stock | $929.0K | -15K -22.92% | 50,440 0.04% of shares | medium |
| Mar 5, 2026 | Callos Andrew Executive | Sell | Common Stock | $928.0K | -15K -19.62% | 61,440 0.04% of shares | medium |
| Jan 5, 2026 | Callos Andrew Executive | Sell | Common Stock | $904.2K | -15K -22.92% | 50,440 0.04% of shares | medium |
| May 5, 2026 | Callos Andrew Executive | Sell | Common Stock | $875.5K | -11K -16.22% | 58,555 0.04% of shares | medium |
| Mar 17, 2026 | Blum Robert I CEO | Sell | Common Stock | $787.6K | -13K -2.71% | 454,258 0.33% of shares | medium |
| Mar 5, 2026 | Callos Andrew Executive | Sell | Common Stock | $680.7K | -11K -17.90% | 50,440 0.04% of shares | medium |
| May 1, 2026 | Callos Andrew Executive | Exercise | Common Stock | $596.7K | +16K +27.08% | 74,412 0.05% of shares | low |
| May 14, 2026 | Blum Robert I CEO | Sell | Common Stock | $584.4K | -8K -1.84% | 400,330 0.29% of shares | medium |
| May 27, 2026 | Blum Robert I CEO | Sell | Common Stock | $579.1K | -8K -1.87% | 392,830 0.28% of shares | medium |
| Jun 15, 2026 | Blum Robert I CEO | Sell | Common Stock | $528.5K | -8K -1.91% | 385,330 0.28% of shares | medium |
| Apr 1, 2026 | Blum Robert I CEO | Sell | Common Stock | $499.7K | -8K -1.74% | 422,830 0.30% of shares | medium |
| Apr 15, 2026 | Callos Andrew Executive | Sell | Common Stock | $491.8K | -7K -11.29% | 58,555 0.04% of shares | medium |
| Apr 15, 2026 | Blum Robert I CEO | Sell | Common Stock | $490.4K | -8K -1.77% | 415,330 0.30% of shares | medium |
| Mar 9, 2026 | Blum Robert I CEO | Sell | Common Stock | $481.6K | -8K -1.98% | 391,673 0.28% of shares | medium |
| Mar 17, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $474.6K | -8K -4.60% | 158,299 0.11% of shares | medium |
| Apr 29, 2026 | Blum Robert I CEO | Sell | Common Stock | $447.1K | -8K -1.81% | 407,830 0.29% of shares | medium |
| May 5, 2026 | Callos Andrew Executive | Exercise | Common Stock | $443.5K | +11K +19.35% | 69,888 0.05% of shares | low |
| Mar 5, 2026 | Callos Andrew Executive | Exercise | Common Stock | $430.4K | +11K +16.81% | 76,440 0.05% of shares | low |
| Jun 24, 2026 | Lee Sung Executive | Exercise | Common Stock | $412.9K | +9K +10.75% | 95,898 0.07% of shares | low |
| Jun 1, 2026 | Parshall B Lynne Director | Sell | Common Stock | $370.4K | -5K -24.06% | 15,784 0.01% of shares | medium |
| Mar 17, 2026 | Callos Andrew Executive | Sell | Common Stock | $349.7K | -6K -7.02% | 74,489 0.05% of shares | medium |
| Jun 1, 2026 | Callos Andrew Executive | Exercise | Common Stock | $348.9K | +15K +25.62% | 73,555 0.05% of shares | low |
| Apr 30, 2026 | Callos Andrew Executive | Exercise | Common Stock | $348.9K | +15K +25.62% | 73,555 0.05% of shares | low |
| Mar 5, 2026 | Callos Andrew Executive | Exercise | Common Stock | $348.9K | +15K +29.74% | 65,440 0.05% of shares | low |
| Feb 5, 2026 | Callos Andrew Executive | Exercise | Common Stock | $348.9K | +15K +29.74% | 65,440 0.05% of shares | low |
| Jan 5, 2026 | Callos Andrew Executive | Exercise | Common Stock | $348.9K | +15K +29.74% | 65,440 0.05% of shares | low |
| Mar 17, 2026 | Lee Sung Executive | Sell | Common Stock | $306.7K | -5K -5.36% | 87,127 0.06% of shares | medium |
| Mar 2, 2026 | Parshall B Lynne Director | Sell | Common Stock | $306.1K | -5K -21.80% | 17,933 0.01% of shares | medium |
| May 5, 2026 | Wierenga Wendell Director | Sell | Common Stock | $302.4K | -4K -11.00% | 32,637 0.02% of shares | medium |
| Jun 23, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $278.3K | -4K -2.22% | 153,902 0.11% of shares | medium |
| Mar 17, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $273.3K | -4K -2.78% | 153,902 0.11% of shares | medium |
| May 5, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $270.8K | -4K -2.22% | 153,902 0.11% of shares | medium |
| Jun 29, 2026 | Lee Sung Executive | Sell | Common Stock | $266.4K | -3K -4.72% | 63,221 0.05% of shares | medium |
| May 19, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $264.9K | -4K -2.22% | 153,902 0.11% of shares | medium |
| Jun 9, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $237.9K | -4K -2.22% | 153,902 0.11% of shares | medium |
| Mar 31, 2026 | Callos Andrew Executive | Sell | Common Stock | $236.5K | -4K -5.23% | 66,004 0.05% of shares | medium |
| Apr 21, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $229.9K | -4K -2.22% | 153,902 0.11% of shares | medium |
| Apr 7, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $228.2K | -4K -2.22% | 153,902 0.11% of shares | medium |
| Jun 1, 2026 | Kaye Edward M. MD Director | Sell | Common Stock | $223.2K | -3K -22.19% | 10,283 <0.01% of shares | medium |
| Mar 17, 2026 | Callos Andrew Executive | Sell | Common Stock | $181.2K | -3K -3.91% | 71,573 0.05% of shares | medium |
| Mar 9, 2026 | Malik Fady Ibraham Executive | Sell | Common Stock | $176.5K | -3K -2.05% | 138,629 0.10% of shares | medium |
| Mar 9, 2026 | Callos Andrew Executive | Sell | Common Stock | $156.8K | -3K -5.12% | 47,858 0.03% of shares | medium |